Mavacamten: Read Past the Trial Status
ODYSSEY-HCM offers a useful exercise in keeping a stopping reason, endpoint results and unanswered questions in their proper places.
THE HIVEPROSPECT WEEKLY
Drug discoveries, difficult failures and the business decisions between them.
Filed under Clinical trial interpretation · Clear filter
ODYSSEY-HCM offers a useful exercise in keeping a stopping reason, endpoint results and unanswered questions in their proper places.
An editorial reading of trial endpoints, reported outcomes, and the questions to ask before discussing a development opportunity.
Inference: the useful question is what the experiment could establish, and which answers still require patient results.